Review



primary antibodies against cd86  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Bioss primary antibodies against cd86
    Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vivo . (A–C) Elisa was used to examine the expression levels of IL-6, TNF-α and IL-10 expression level. (D–F) Real-time qRT-PCR analysis of the relative mRNA expression of TMEM119 , iNOS , and Arg1 in the DLPFC. (G, H) Immunofluorescence staining of Iba-1, M1-type <t>(CD86)</t> and M2-type (CD206) markers in the left PFC region. (I, J) Proportion of positive cells for target proteins. The number of samples in each group is 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ***P < 0.001.
    Primary Antibodies Against Cd86, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 113 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Bioss
    Average 95 stars, based on 113 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-05
    95/100 stars

    Images

    1) Product Images from "Repetitive transcranial magnetic stimulation alleviates neuropathic pain via microglial polarization by modulating the METTL3/NMDAR2B/NLRP3 pathway"

    Article Title: Repetitive transcranial magnetic stimulation alleviates neuropathic pain via microglial polarization by modulating the METTL3/NMDAR2B/NLRP3 pathway

    Journal: Frontiers in Immunology

    doi: 10.3389/fimmu.2025.1666920

    Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vivo . (A–C) Elisa was used to examine the expression levels of IL-6, TNF-α and IL-10 expression level. (D–F) Real-time qRT-PCR analysis of the relative mRNA expression of TMEM119 , iNOS , and Arg1 in the DLPFC. (G, H) Immunofluorescence staining of Iba-1, M1-type (CD86) and M2-type (CD206) markers in the left PFC region. (I, J) Proportion of positive cells for target proteins. The number of samples in each group is 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ***P < 0.001.
    Figure Legend Snippet: Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vivo . (A–C) Elisa was used to examine the expression levels of IL-6, TNF-α and IL-10 expression level. (D–F) Real-time qRT-PCR analysis of the relative mRNA expression of TMEM119 , iNOS , and Arg1 in the DLPFC. (G, H) Immunofluorescence staining of Iba-1, M1-type (CD86) and M2-type (CD206) markers in the left PFC region. (I, J) Proportion of positive cells for target proteins. The number of samples in each group is 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ***P < 0.001.

    Techniques Used: In Vivo, Enzyme-linked Immunosorbent Assay, Expressing, Quantitative RT-PCR, Immunofluorescence, Staining

    Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vitro . (A–D) Elisa was used to examine the expression levels of NLRP3, IL-6, TNF-α and IL-10 expression level. (E–G) Immunofluorescence staining of Iba-1, CD86, CD206. (H–J) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ****P < 0.0001.
    Figure Legend Snippet: Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vitro . (A–D) Elisa was used to examine the expression levels of NLRP3, IL-6, TNF-α and IL-10 expression level. (E–G) Immunofluorescence staining of Iba-1, CD86, CD206. (H–J) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ****P < 0.0001.

    Techniques Used: In Vitro, Enzyme-linked Immunosorbent Assay, Expressing, Immunofluorescence, Staining

    The roles of METTL3 and NMDAR2B in the regulation of microglial cell polarization by magnetic stimulation in vitro . (A–C, G–I) Immunofluorescence staining of Iba-1, CD86 and CD206. (D–F, J–L) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.
    Figure Legend Snippet: The roles of METTL3 and NMDAR2B in the regulation of microglial cell polarization by magnetic stimulation in vitro . (A–C, G–I) Immunofluorescence staining of Iba-1, CD86 and CD206. (D–F, J–L) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.

    Techniques Used: In Vitro, Immunofluorescence, Staining



    Similar Products

    95
    Bioss primary antibodies against cd86
    Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vivo . (A–C) Elisa was used to examine the expression levels of IL-6, TNF-α and IL-10 expression level. (D–F) Real-time qRT-PCR analysis of the relative mRNA expression of TMEM119 , iNOS , and Arg1 in the DLPFC. (G, H) Immunofluorescence staining of Iba-1, M1-type <t>(CD86)</t> and M2-type (CD206) markers in the left PFC region. (I, J) Proportion of positive cells for target proteins. The number of samples in each group is 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ***P < 0.001.
    Primary Antibodies Against Cd86, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Bioss
    Average 95 stars, based on 1 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc primary antibodies against cd86
    (A) Chemical structure of ATG. (B) Target prediction of ATG. (C) Molecular targets associated with MAFLD. (D) Intersection of ATG-specific and MAFLD-related targets. (E) The PPI network of intersection targets between ATG and MAFLD-related targets. (F) GO enrichment analysis of the intersected targets. (G–H) Enrichment of KEGG pathway (G) and Reactome pathway (H) of ATG’s targets. (I–J) Immunofluorescence analysis of the colocalization of NLRP3 and <t>CD86</t> in mice liver from four groups (scale bar: 20 µm), staining intensity was quantified, and colocation analysis was performed. (K) NLRP3 with ATG bound to the cavity. (L) Western blot of CETSA experiment to further confirm the interaction between NLRP3 and ATG in RAW264.7 cells, the temperature ranges from 49°C to 61°C, with relative band intensity normalized to 49°C. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ATG, arctigenin; MAFLD, metabolic dysfunction-associated fatty liver disease; PPI, protein-protein interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes; NLRP3, NLR family pyrin domain containing 3; SEM, standard error of the mean.
    Primary Antibodies Against Cd86, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    96
    Proteintech primary antibodies against cd86
    (A) Chemical structure of ATG. (B) Target prediction of ATG. (C) Molecular targets associated with MAFLD. (D) Intersection of ATG-specific and MAFLD-related targets. (E) The PPI network of intersection targets between ATG and MAFLD-related targets. (F) GO enrichment analysis of the intersected targets. (G–H) Enrichment of KEGG pathway (G) and Reactome pathway (H) of ATG’s targets. (I–J) Immunofluorescence analysis of the colocalization of NLRP3 and <t>CD86</t> in mice liver from four groups (scale bar: 20 µm), staining intensity was quantified, and colocation analysis was performed. (K) NLRP3 with ATG bound to the cavity. (L) Western blot of CETSA experiment to further confirm the interaction between NLRP3 and ATG in RAW264.7 cells, the temperature ranges from 49°C to 61°C, with relative band intensity normalized to 49°C. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ATG, arctigenin; MAFLD, metabolic dysfunction-associated fatty liver disease; PPI, protein-protein interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes; NLRP3, NLR family pyrin domain containing 3; SEM, standard error of the mean.
    Primary Antibodies Against Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    86
    Servicebio Inc primary antibodies against cd86
    (A) Chemical structure of ATG. (B) Target prediction of ATG. (C) Molecular targets associated with MAFLD. (D) Intersection of ATG-specific and MAFLD-related targets. (E) The PPI network of intersection targets between ATG and MAFLD-related targets. (F) GO enrichment analysis of the intersected targets. (G–H) Enrichment of KEGG pathway (G) and Reactome pathway (H) of ATG’s targets. (I–J) Immunofluorescence analysis of the colocalization of NLRP3 and <t>CD86</t> in mice liver from four groups (scale bar: 20 µm), staining intensity was quantified, and colocation analysis was performed. (K) NLRP3 with ATG bound to the cavity. (L) Western blot of CETSA experiment to further confirm the interaction between NLRP3 and ATG in RAW264.7 cells, the temperature ranges from 49°C to 61°C, with relative band intensity normalized to 49°C. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ATG, arctigenin; MAFLD, metabolic dysfunction-associated fatty liver disease; PPI, protein-protein interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes; NLRP3, NLR family pyrin domain containing 3; SEM, standard error of the mean.
    Primary Antibodies Against Cd86, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86/product/Servicebio Inc
    Average 86 stars, based on 1 article reviews
    primary antibodies against cd86 - by Bioz Stars, 2026-05
    86/100 stars
      Buy from Supplier

    90
    Thermo Fisher primary antibodies against cd86 pa5–114995
    (A) Chemical structure of ATG. (B) Target prediction of ATG. (C) Molecular targets associated with MAFLD. (D) Intersection of ATG-specific and MAFLD-related targets. (E) The PPI network of intersection targets between ATG and MAFLD-related targets. (F) GO enrichment analysis of the intersected targets. (G–H) Enrichment of KEGG pathway (G) and Reactome pathway (H) of ATG’s targets. (I–J) Immunofluorescence analysis of the colocalization of NLRP3 and <t>CD86</t> in mice liver from four groups (scale bar: 20 µm), staining intensity was quantified, and colocation analysis was performed. (K) NLRP3 with ATG bound to the cavity. (L) Western blot of CETSA experiment to further confirm the interaction between NLRP3 and ATG in RAW264.7 cells, the temperature ranges from 49°C to 61°C, with relative band intensity normalized to 49°C. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ATG, arctigenin; MAFLD, metabolic dysfunction-associated fatty liver disease; PPI, protein-protein interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes; NLRP3, NLR family pyrin domain containing 3; SEM, standard error of the mean.
    Primary Antibodies Against Cd86 Pa5–114995, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against cd86 pa5–114995/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    primary antibodies against cd86 pa5–114995 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vivo . (A–C) Elisa was used to examine the expression levels of IL-6, TNF-α and IL-10 expression level. (D–F) Real-time qRT-PCR analysis of the relative mRNA expression of TMEM119 , iNOS , and Arg1 in the DLPFC. (G, H) Immunofluorescence staining of Iba-1, M1-type (CD86) and M2-type (CD206) markers in the left PFC region. (I, J) Proportion of positive cells for target proteins. The number of samples in each group is 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ***P < 0.001.

    Journal: Frontiers in Immunology

    Article Title: Repetitive transcranial magnetic stimulation alleviates neuropathic pain via microglial polarization by modulating the METTL3/NMDAR2B/NLRP3 pathway

    doi: 10.3389/fimmu.2025.1666920

    Figure Lengend Snippet: Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vivo . (A–C) Elisa was used to examine the expression levels of IL-6, TNF-α and IL-10 expression level. (D–F) Real-time qRT-PCR analysis of the relative mRNA expression of TMEM119 , iNOS , and Arg1 in the DLPFC. (G, H) Immunofluorescence staining of Iba-1, M1-type (CD86) and M2-type (CD206) markers in the left PFC region. (I, J) Proportion of positive cells for target proteins. The number of samples in each group is 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ***P < 0.001.

    Article Snippet: Primary antibodies against CD86 (1:100; bs-1035r; Bioss), CD206 (1:100; #24595; CST) and Iba-1(1:100, ab283319, Abcam, Cambridge, UK)were applied, and the sections were incubated overnight at 4 °C.

    Techniques: In Vivo, Enzyme-linked Immunosorbent Assay, Expressing, Quantitative RT-PCR, Immunofluorescence, Staining

    Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vitro . (A–D) Elisa was used to examine the expression levels of NLRP3, IL-6, TNF-α and IL-10 expression level. (E–G) Immunofluorescence staining of Iba-1, CD86, CD206. (H–J) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ****P < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Repetitive transcranial magnetic stimulation alleviates neuropathic pain via microglial polarization by modulating the METTL3/NMDAR2B/NLRP3 pathway

    doi: 10.3389/fimmu.2025.1666920

    Figure Lengend Snippet: Effects of rTMS on neuroinflammation and the M1/M2 polarization state of microglia in vitro . (A–D) Elisa was used to examine the expression levels of NLRP3, IL-6, TNF-α and IL-10 expression level. (E–G) Immunofluorescence staining of Iba-1, CD86, CD206. (H–J) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01 and ****P < 0.0001.

    Article Snippet: Primary antibodies against CD86 (1:100; bs-1035r; Bioss), CD206 (1:100; #24595; CST) and Iba-1(1:100, ab283319, Abcam, Cambridge, UK)were applied, and the sections were incubated overnight at 4 °C.

    Techniques: In Vitro, Enzyme-linked Immunosorbent Assay, Expressing, Immunofluorescence, Staining

    The roles of METTL3 and NMDAR2B in the regulation of microglial cell polarization by magnetic stimulation in vitro . (A–C, G–I) Immunofluorescence staining of Iba-1, CD86 and CD206. (D–F, J–L) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Repetitive transcranial magnetic stimulation alleviates neuropathic pain via microglial polarization by modulating the METTL3/NMDAR2B/NLRP3 pathway

    doi: 10.3389/fimmu.2025.1666920

    Figure Lengend Snippet: The roles of METTL3 and NMDAR2B in the regulation of microglial cell polarization by magnetic stimulation in vitro . (A–C, G–I) Immunofluorescence staining of Iba-1, CD86 and CD206. (D–F, J–L) Proportion of positive cells for target proteins. The number of samples in each group was 3. The results was analyzed with one-way ANOVA followed by Tukey’s post-hoc test, *p < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001.

    Article Snippet: Primary antibodies against CD86 (1:100; bs-1035r; Bioss), CD206 (1:100; #24595; CST) and Iba-1(1:100, ab283319, Abcam, Cambridge, UK)were applied, and the sections were incubated overnight at 4 °C.

    Techniques: In Vitro, Immunofluorescence, Staining

    (A) Chemical structure of ATG. (B) Target prediction of ATG. (C) Molecular targets associated with MAFLD. (D) Intersection of ATG-specific and MAFLD-related targets. (E) The PPI network of intersection targets between ATG and MAFLD-related targets. (F) GO enrichment analysis of the intersected targets. (G–H) Enrichment of KEGG pathway (G) and Reactome pathway (H) of ATG’s targets. (I–J) Immunofluorescence analysis of the colocalization of NLRP3 and CD86 in mice liver from four groups (scale bar: 20 µm), staining intensity was quantified, and colocation analysis was performed. (K) NLRP3 with ATG bound to the cavity. (L) Western blot of CETSA experiment to further confirm the interaction between NLRP3 and ATG in RAW264.7 cells, the temperature ranges from 49°C to 61°C, with relative band intensity normalized to 49°C. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ATG, arctigenin; MAFLD, metabolic dysfunction-associated fatty liver disease; PPI, protein-protein interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes; NLRP3, NLR family pyrin domain containing 3; SEM, standard error of the mean.

    Journal: Journal of Clinical and Translational Hepatology

    Article Title: Arctigenin Prevents Metabolic Dysfunction-associated Steatohepatitis by Inhibiting NLRP3/GSDMD-N Axis in Macrophages

    doi: 10.14218/JCTH.2025.00141

    Figure Lengend Snippet: (A) Chemical structure of ATG. (B) Target prediction of ATG. (C) Molecular targets associated with MAFLD. (D) Intersection of ATG-specific and MAFLD-related targets. (E) The PPI network of intersection targets between ATG and MAFLD-related targets. (F) GO enrichment analysis of the intersected targets. (G–H) Enrichment of KEGG pathway (G) and Reactome pathway (H) of ATG’s targets. (I–J) Immunofluorescence analysis of the colocalization of NLRP3 and CD86 in mice liver from four groups (scale bar: 20 µm), staining intensity was quantified, and colocation analysis was performed. (K) NLRP3 with ATG bound to the cavity. (L) Western blot of CETSA experiment to further confirm the interaction between NLRP3 and ATG in RAW264.7 cells, the temperature ranges from 49°C to 61°C, with relative band intensity normalized to 49°C. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. ATG, arctigenin; MAFLD, metabolic dysfunction-associated fatty liver disease; PPI, protein-protein interaction; KEGG, Kyoto Encyclopedia of Genes and Genomes; NLRP3, NLR family pyrin domain containing 3; SEM, standard error of the mean.

    Article Snippet: Primary antibodies against CD86 (19589, Cell Signaling Technology, CST®; 1:400 in 3% BSA) and α-SMA (ab124964, Abcam®; 1:2,000 in 3% BSA) were incubated overnight.

    Techniques: Immunofluorescence, Staining, Western Blot